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The aim was to investigate how measurements of the lipidome differ according to the level and 40 
intensity of physical activity in a population at high risk of type 2 diabetes (T2DM). A targeted 41 
metabolomics platform provided quantitative molecular data on lipid species. Linear regression 42 
examined the associations between plasma lipid concentrations, particle size and time spent in 43 
objectively measured physical activity intensity domains, in increments of 500 counts per 44 
minute (cpm) (up to >4500cpm (~>5.6METs)). Results are presented as % difference in the 45 
concentration (lower/higher) or particle size (smaller/larger) per 10 minutes of activity within 46 
each intensity. 509 participants were included. Time spent in the lowest physical activity 47 
intensity domain (<500cpm) was unfavourably associated with VLDL (2%), HDL (-2%) and 48 
Apolipoprotein A-1 particle concentrations (-2%) and HDL diameter (-2%). Conversely, time 49 
spent in intensities ≥1000cpm were favourably associated with HDL subclass concentrations; 50 
with stronger associations seen at moderate intensities (2000-3999cpm (~4.5METs)). For 51 
Apolipoprotein-B concentration and VLDL particle concentration and size,  a negative 52 
association was consistently observed at the highest physical activity intensity only. If these 53 
associations are causal, HDL subclasses appear sensitive to light-intensities whereas only the 54 
high category of physical activity intensity was consistently associated with VLDL subclasses.  55 
 56 
 57 






















Previous research has consistently demonstrated that individuals who engage in physical 78 
activity, particularly moderate-to-vigorous intensity (MVPA), on a regular basis manifest a 79 
myriad of physiological benefits related to lipid metabolism (1). For example, HDL-C 80 
(including very large HDL particle concentrations) is generally responsive to physical activity 81 
and increases in a dose-dependent manner with increased energy expenditure (2,3). 82 
Conversely, physical inactivity (the failure to achieve the minimum activity recommendations 83 
for health (4)), and sedentary behaviour (any sitting or reclining activity with low energy 84 
expenditure (5)) are each independently associated with an increased risk of cardiovascular and 85 
all-cause mortality (6,7), primarily driven by a worsening of atherogenic dyslipidemia, which 86 
includes reduced  HDL-C and so potentially greater non-HDL-C levels (7). In contrast, the 87 
impact of exercise and inactivity on LDL-C, triglycerides and triglyceride rich lipoproteins are 88 
less consistent (8).  89 
 90 
Lipidomics is a sub-class of metabolomics focussing on the structure and function of lipids and 91 
lipid derivatives (e.g. phospholipids). These molecules may aid in pinpointing the molecular 92 
pathways linking health and disease and how they are influenced by lifestyle behaviours, such 93 
as physical activity (9). Historically, many studies have focused exclusively upon the 94 
metabolite response to exercise training (10,11). More recently, studies have also reported 95 
associations in relation to habitual physical activity and sedentary behaviour across multiple 96 
metabolite networks (3,12,13). 97 
 98 
However, there has been limited research on lipidomics and physical activity in populations at 99 
high risk of chronic disease.  This is an important limitation as international recommendations 100 
and policies specify that chronic disease prevention strategies should include targeted 101 
interventions aimed at the identification and management of high-risk individuals (14,15). 102 
Therefore, the importance of sedentary behaviour and physical activity in this group needs 103 
to be better understood in order to inform the content and structure of prevention 104 
programmes. Moreover, previous investigations have typically categorised sedentary 105 
behaviour and physical activity (light, moderate, vigorous) using population-dependent 106 
thresholds. Using a broader continuum of intensity categories allows for greater insight into 107 
the dose–response relationship between physical activity intensity and health outcomes (16). 108 
This is important as previous research has typically focused on MVPA, which occupies a very 109 
4 
 
small fraction of the day, if at all. Conversely, substantial cardiometabolic benefits may be 110 
gained from light‐intensity activity, particularly in those at high risk of chronic disease (17), 111 
which may also represent a more feasible means to increasing overall activity volume.  112 
Applying this approach to measurements of the lipidome may allow for greater understanding 113 
of how lipid metabolism differs across the precise physical activity intensity spectrum.  114 
 115 
Therefore, the aim of this study was to explore the associations between circulating lipid 116 
species and various physical activity intensities in a population at high risk of type 2 diabetes 117 
mellitus (T2DM). 118 
 119 
Materials and Methods 120 
 121 
Study population 122 
 123 
This study reports cross-sectional baseline data from the Walking Away from Diabetes study. 124 
Participants were recruited through 10 primary care practices in Leicestershire, UK (18). 125 
Individuals at increased risk of impaired glucose regulation (IGR; any combination of impaired 126 
glucose tolerance (IGT) and/or impaired fasting glycaemia (IFG) or undiagnosed T2DM) were 127 
identified for recruitment using a modified version of the Leicester Risk Score (19). This risk 128 
scoreapplies a validated algorithm to routinely collected data within primary care; based on 129 
age, sex, BMI, ethnicity, prescribed antihypertensives, and family history of diabetes. Those 130 
individuals scoring within the 90th percentile in each practice were invited to take part in the 131 
study. This approach has reasonable sensitivity and specificity for identifying participants with 132 
IGR (19). Individuals were unaware of their diabetes risk status before entering the study. 133 
Those who had previously been diagnosed with T2DM, were currently taking steroids or were 134 
unable to take part in any walking were excluded. Written informed consent was obtained from 135 
all eligible participants and the study had full ethical and governance approval. 136 
 137 
Accelerometer derived measures of physical activity 138 
 139 
All eligible participants were asked to wear an accelerometer, (Actigraph GT3X, Florida, 140 
USA), around their waist, for seven consecutive days during waking hours. These 141 
accelerometers translate raw accelerations into activity counts. Data were recorded in 15-s 142 
epochs and reintegrated into 60-s epoch files for this analysis. Non-wear time was defined as a 143 
5 
 
minimum of 60 minutes of continuous zero counts; days with at least 600 minutes of wear time 144 
were considered valid. In order to be included in the analysis, participants required a minimum 145 
of any four valid days (20).  146 
 147 
A commercially available data analysis tool (KineSoft version 3.3.76, Kinesoft, 148 
Loughborough, UK; www.kinesoft.org) was used to process the accelerometer data. Activity 149 
intensity was generated in increments of 500 counts per minute (cpm) from 0 to 4499cpm for 150 
each participant who met the inclusion criteria for accelerometer wear time; with the 151 
corresponding categories (0-499, 500-999, 1000-1499, 1500-1999, 2000-2499, 2500-2999, 152 
3000-3499, 3500-3999, 4000-4499) representing a summation of all included individuals. Any 153 
counts above 4500 were amalgamated, due to a lack of power at higher intensities. For 154 
descriptive purposes and to aid interpretation, we used the following thresholds to group 500 155 
cpm increments into: very low intensities of physical activity or sedentary behaviour 156 
(<500cpm); light-intensity physical activity (≥500-<2000cpm) and MVPA (≥2000 counts per 157 
minute); these thresholds were are broadly comparable to those that have been commonly used 158 
in the literature (21-23). 159 
 160 
Blood sample collection and lipidomics analysis 161 
 162 
Lipids were measured from Ethylenediaminetetraacetic acid (EDTA) plasma samples, obtained 163 
following an overnight fast and avoidance of alcohol and MVPA for 48 hours previously.  The 164 
level of systemic lipids in the fasting state arise from a broad combination of genetic and 165 
lifestyle related factors.  As such, the nuclear magnetic resonance (NMR) spectroscopy 166 
metabolomics platform provides a comprehensive snapshot of the individual’s physiological 167 
status as reflected in their systemic metabolism (9).  168 
 169 
Analysis was performed by Nightingale Health (Helsinki, Finland), whose platform and 170 
procedures have been described elsewhere (9). Given the fact that the chosen NMR spectra 171 
allows significant modelling of lipoprotein subclasses (24), coupled with the previous 172 
epidemiological work showing associations between sedentary time, physical activity and 173 
cardiovascular outcomes (6,20,25), the targeted focus of our analysis was on lipid species.  174 
 175 
Briefly, plasma samples were analysed using an automated high-throughput NMR workflow, 176 
acquiring NMR spectra on either a Bruker AVANCE III 500 MHz or Bruker AVANCE III HD 177 
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600 MHz spectrometer.  Following organic solvent lipid extraction, further NMR spectra were 178 
acquired from the lipid extracts on the 600 MHz spectrometer. The initial data processing, 179 
including the Fourier transformations to NMR spectra and automated phasing were performed 180 
using computers that control the spectrometers. The spectra were then automatically transferred 181 
to a centralized server, which performs various automated spectral processing steps, including 182 
overall signal check for missing/extra peaks, background control, baseline removal and spectral 183 
area-specific signal alignments (9). The spectral information also underwent various 184 
comparisons with the spectra of 2 quality control samples; the data for which is also followed 185 
and compared in a consecutive manner. For those spectral areas that passed all the quality 186 
control steps, regression modelling was performed to produce the quantified molecular data. 187 
Individual metabolic measures also underwent various statistical quality control steps and were 188 
checked against an extensive database of quantitative molecular data (9). All analyses were 189 
conducted by individuals blinded to the participants' identity and physical activity levels. As 190 
traditional clinical lipid profile may not fully capture meaningful information with regards to 191 
cardiometabolic risk (26), we report the concentration of particles (“number”) within 192 
subclasses of VLDL, HDL, IDL and LDL, apolipoprotein concentration (Apolipoprotein-A1 193 
(Apo-A1) and  Apo B) and the ratio of Apo B to Apo-A1. We also report the mean diameter 194 
particle size of VLDL, HDL and LDL.  195 
  196 
Covariates 197 
 198 
Information on smoking status and ethnicity was obtained following an interview administered 199 
protocol conducted by a healthcare professional. We were also able to adjust for available 200 
dietary biomarkers (omega-3 and omega 6 fatty acids) which are reflective of the composition 201 
of ingested fatty acids (27) and act as lipid mediators in the inflammatory response (28). In 202 
addition, an increasing dietary ratio of omega-3/omega 6 fatty acids has been associated with 203 
a higher incidence of obesity, cardiovascular disease (CVD), metabolic syndrome and insulin 204 
resistance (28-30). Conversely, diets including high amounts of seafood and fish increase the 205 
dietary amount of omega-3 and have been linked to a reduced risk of CVD, T2DM and 206 







Statistical analysis 212 
 213 
Linear regression was used to examine the associations between lipid type concentrations, 214 
particle size and physical activity intensities. All lipid outcomes were log-transformed, 215 
standardised (Z score) and centered (mean =0, standard deviation =1). Any value that was 216 
below detection was set to the minimum observed value of the corresponding lipid. Time spent 217 
in each of the physical activity intensity increments was entered into models individually 218 
because of the high correlation between intensities (Table S1). Models were adjusted for age 219 
(continuous), sex (categorical), smoking status (categorical), ethnicity (categorical),, time 220 
accelerometer worn (continuous; average minutes per day) and omega-3 and 6 fatty acids 221 
(continuous).  222 
 223 
Results are presented as % difference in the lipid variable associated with 10 minutes of each 224 
activity within each intensity. Two-tailed p values of <0.05 were considered statistically 225 
significant. No further adjustment was made for multiple comparisons, therefore data were 226 
viewed with caution and in relation to the overall pattern of results. All statistical analyses were 227 




A total of 509 participants had complete lipidomic and accelerometer data (63% of total 232 
sample). The main reasons for participants not having complete data was insufficient 233 
accelerometer wear time over too few days and insufficient volumes of blood for additional 234 
analyses. There was no difference in the proportions of males/females, ethnicity, smoking 235 
status or age in those included vs. those excluded. Table 1 displays the characteristics of 236 
included study participants.  237 
 238 
Physical activity 239 
 240 
The average time spent in each 500cpm intensity banding is shown in Table 1. 82.4% of total 241 
accelerometer wear time was spent in the lowest physical activity category (<500cpm), 242 
compared with 0.3% in the highest activity category (>4500cpm). Table S1 also displays the 243 
correlations between each intensity band.  244 
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Lipoprotein concentrations and particle size  245 
 246 
The associations between lipid sub-type particle concentrations and physical activity intensities 247 
(in 500cpm increments, per 10 minutes of activity) are displayed in Figure 1 with associations 248 
for apolipoprotein concentration displayed in Figure 2 (corresponding values presented in 249 
Tables S2 and S3). Figure 3 displays the associations between particle size and physical activity 250 
intensities. 251 
 252 
Lipoprotein subclass HDL 253 
 254 
Concentrations of both large and medium HDL particles showed negative associations with 255 
time spent in the lowest intensity of physical activity, which is likely to include a significant 256 
amount of sedentary behaviour (<500cpm (both -2%; 95% CI= -3% to -1%, per 10 minutes of 257 
activity)) (Figure 1A, Table S3). Time spent in physical activity intensities >1000cpm were 258 
favourably associated with small and medium HDL subclasses (range = 3%-24%) with results 259 
displaying a dose response relationship for medium subclasses up to moderate intensities. 260 
Concentration of very large HDL particles were only associated with time spent in the highest 261 
intensity of physical activity (>4500cpm).   262 
 263 
Lipoprotein subclass VLDL 264 
 265 
Time spent in the lowest physical activity intensity band (<500cpm) was negatively associated 266 
with the concentration of very large, large, medium and small VLDL particles (2%; 95% CI= 267 
1% to 3%, per 10 minutes of activity) (Figure 2A, Figure 2C; Table S3). For higher intensities 268 
of physical activity, the majority of VLDL subclasses were only found to be favourably 269 
associated with time spent in the highest intensity category (>4500cpm). 270 
Concentration of IDL and LDL particles 271 
 272 
There was no association between physical activity intensities and IDL particle concentrations, 273 
whereas LDL particle concentrations (small, medium and large) were only associated at 3500-274 








Apo-A1 was negatively associated with physical activity <500cpm (-2%; 95% CI= -3% to -281 
1%, per 10 minutes of activity; Figure 2). Even low levels of activity (≥500cpm) yielded 282 
positive associations, with significant results seen up to >4500cpm (range = 3-20%). For Apo 283 
B, significant negative associations were seen from moderate (2500-2999cpm) through to the 284 
highest physical activity intensity (>4500cpm) (range =-1% to -15%). The ratio of Apo B to 285 
Apo-A1 also displayed negative associations as the physical activity intensity increased, with 286 
significant results seen at >2500cpm (range = -11% to -23%).  287 
 288 
Lipoprotein particle size 289 
 290 
Time spent in the lowest intensity of physical activity (<500cpm) was significantly associated 291 
with a higher mean diameter of VLDL (2% (95% CI = 1% to 3%, per 10 minutes of activity)) 292 
and lower mean diameter of HDL (-2% (95% CI= -3% to -1%, per 10 minutes of activity)) 293 
particles (Figure 3; Table S2). As the physical activity intensity increased, there was a dose-294 
response relationship for HDL, with greater intensity associated with a larger particle size, 295 
whereas differences in VLDL particle size were observed at the lowest (<500cpm, 500-296 
999cpm, 1000-1499cpm)and highest physical activity intensities (>4500cpm). No associations 297 




This study highlights the dose-response associations between physical activity intensity and 302 
lipid species involved in the underlying pathophysiology of insulin resistance, CVD and 303 
physical activity in a population at high risk of T2DM. The most consistent associations were 304 
seen in the HDL and VLDL subclass concentrations.  Associations between VLDL subclass 305 
concentrations and physical activity were consistently only evident at the lowest (<500cpm, 306 
approximately <2.6 METs (33)) and highest intensity of physical activity (>4500cpm, 307 
approximately >5.6 METs (33)). Conversely, although results for concentrations of very large 308 
HDL particles mirrored those for VLDL,  those for smaller HDL particles and Apo-A1 showed 309 
significant adverse associations with time spent in the lowest category of physical activity 310 
(<500cpm) and positive associations across the spectrum of light- and moderate-intensity 311 
physical activity. These results suggest that engaging in different intensities of physical activity 312 
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may result in a differential impact on lipid metabolism, with high intensities of physical activity 313 
needed to disrupt the hepatic release of VLDL.   314 
 315 
To our knowledge, this is the first study to specifically investigate the association of a spectrum 316 
of intensities of objectively assessed physical activity on the lipidome, with the findings 317 
extending previous research using broad categories of physical activity. For example, a 318 
previous study in twins reported that compared to inactive individuals, active individuals had 319 
a shift towards lower levels of VLDL and higher levels of large and very large HDL (3). Our 320 
findings give insight into how physical activity intensity contributes to these observations, with 321 
most HDL subclass concentrations and Apo-A1 being sensitive to time spent in lower 322 
intensities of physical activity, whereas lower levels of VLDL subclasses and Apo B were 323 
consistently only associated with a moderate to high intensity of physical activity. The results 324 
for VLDL and Apo B are consistent with previous research suggesting that the intensity of 325 
aerobic exercise must surpass that of moderate intensity in order to have a favourable effect on 326 
non HDL-lipids, with adaptations largely modulated through glucagon stimulation (34,35). 327 
 328 
For HDL-cholesterol concentrations and Apo A-1 , associations were consistently seen across 329 
light and moderate intensities of physical activity up to a threshold of between 2500–3500cpm 330 
(approximately 3.7-4.4 METs (33)), after which little additional benefit was observed. This 331 
intensity of physical activity is equivalent to walking at ~5km/h and is considered at the lower 332 
end of the moderate intensity spectrum (36). Our finding for HDL subclasses is somewhat in 333 
agreement with a recently published study of 66 metabolome measures, which found that 334 
higher cardiorespiratory fitness, for which moderate intensities of physical activity are an 335 
important determinant, was associated with greater concentrations of larger HDL-particles 336 
(37).  Our findings are also broadly consistent with a meta-analysis of exercise training studies 337 
which concluded that duration, and not intensity, is a predictor of the HDL-C response (38). It 338 
has also been shown that low-intensity exercise may improve reverse cholesterol transport via 339 
the activation of gene transcription variables proliferator-activated receptor gamma 340 
(PPARgamma) and liver X receptor alpha (LXRalpha) (39). HDL-cholesterol may also be 341 
affected by other physiological processes, such as inflammation (40), which may be influenced 342 
by overall volumes of physical activity (41). Therefore, these data suggest that both light-343 
intensity and moderate-intensity physical activity interventions are effective at improving 344 
HDL-C concentrations, whereas engaging in higher-intensities of physical activity may not 345 




A further novel finding was that the time spent in moderate intensities of physical activity were 348 
associated with larger average HDL-C particle size. Larger HDL particles are hypothesised to 349 
be more important in promoting health benefits and thus reducing the risk of CVD (42). 350 
Therefore, one of the many mechanisms linking moderate physical activity to cardiometabolic 351 
health could be through altering HDL particle size. Previous studies have also reported stronger 352 
associations between self-reported physical activity status and greater effects of exercise 353 
intervention studies on large HDL compared to smaller particles (43).   That noted, we accept 354 
that recent trials and genetics have placed a question on the causal link between HDL-C and 355 
CVD (44).  356 
 357 
Our findings also extend previous findings by showing that low levels of physical activity 358 
(<500cpm), indicative of sedentary behaviour, are detrimentally associated with HDL 359 
concentrations (20,45). Interestingly, the time spent below 500cpm was also detrimentally 360 
associated with Apo-A1 and the concentration of very large, large, medium and small VLDL 361 
particles. VLDLs are substrates for lipoprotein lipase (LPL)-mediated triglyceride removal, 362 
with larger VLDL particles carrying more triglycerides than smaller particles and correlating 363 
with insulin resistance (46). Although the precise mechanism of sedentary behaviour and 364 
(in)activity-induced lipid changes are unclear, muscle LPL regulation is thought to be one of 365 
the most sensitive metabolic responses to sedentary behaviour and low‐intensity contractile 366 
activity and may explain why even small amounts of physical activity appear to confer 367 
cardiovascular benefits (47). The mechanistic relevance of LPL to sedentary behaviour has 368 
been demonstrated in animal models (48) whereas in humans moderate intensity activity was 369 
shown to increase the affinity of large VLDL particles for LPL clearance (49). However, 370 
further insight is needed into the precise impact of increased sedentary time and reduced 371 
physical activity on LPL activity.  372 
 373 
Strengths and limitations 374 
 375 
Strengths of our study include the objective measurement of physical activity and examination 376 
of lipids in relation to different characteristics across a range of physical activity intensities. 377 
By enabling identification of the minimum intensity at which benefits may occur as well as a 378 
quantifiable dose–response relationship, this information may aid in generating hypotheses to 379 
be tested in future physical activity interventions. Furthermore, our targeted metabolomic 380 
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platform covered a wide variety of lipids with known identity and quantitative measurements. 381 
Our results are strengthened by the fact that associations with all lipoprotein subclasses were 382 
present after adjusting for dietary biomarkers (omega-3 and omega 6), supporting an 383 
independent association of physical (in) activity per se on the lipoprotein subclass profile. 384 
These results are in agreement with previous studies which have shown that significant changes 385 
in HDL and VLDL concentrations and particle size after exercise training are independent of 386 
diet (43). Our study is also accompanied by important limitations. For example, despite 387 
individuals spending a reasonable amount of time in moderate activity, the time spent in higher, 388 
more vigorous intensity activities is limited. However, this is likely reflective of the habitual 389 
behaviour of the majority of individuals at high risk of T2DM.  This coupled with the fact that 390 
our analysis is observational, means that we  cannot prove biological mechanisms or 391 
demonstrate causality; reverse causality is also a possibility whereby those with a greater 392 
burden of risk factors may be less likely to engage in greater volumes or intensities of physical 393 
activity The high risk nature of the cohort, where higher relative exercise intensities can be 394 
anticipated for a given exercise compared to a healthy population, may also affect the 395 
interpretation of the intensity thresholds used for this study. However, this is unlikely to affect 396 
the interpretation for HDL-cholesterol, where associations were seen across sedentary time and 397 
the lower intensity spectrums. Furthermore, despite adjusting for a range of potential 398 
cofounders, residual confounding or confounding from unmeasured factors remains a 399 
possibility (e.g. alcohol intake). Finally, although accelerometers allow for more robust 400 
assessments of physical activity compared to self-report, they are not without limitations. They 401 
rely on categorising movement (acceleration) strength, rather than directly distinguishing 402 
between postures or modes of physical activity.  403 
 404 
In conclusion, our data suggests potential differences in the associations between different 405 
physical activity intensities and the lipidome in subjects with a high risk of T2DM, with most 406 
HDL subclass and Apo A-1 concentrations appearing sensitive to light-intensities of physical 407 
activity.  Although structured physical activity should remain a strong focus and end point of 408 
behavioural interventions, lipid related benefits may be gained through light-intensity activity 409 
(whilst also reducing sedentary time). Given the limited time spent in higher intensity activities 410 
in this population, this may also be the option that is best tolerated in those at high risk of 411 
chronic disease. This is particularly pertinent as they are also representative of those likely to 412 
be identified as being at high risk of T2DM within routine care and referred onto available 413 
prevention programmes. Therefore, future interventions that encourage increases in physical 414 
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activity, may need to be tailored to individual characteristics and tolerability. In particular, 415 
consideration should be given to the relative intensity of physical activity prescribed, as the 416 
absolute values will differ considerably between individuals The results of this analysis also 417 
highlight the fact that more work is needed to elucidate the mechanisms by which different 418 
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Data presented as mean ± standard deviation, median (interquartile range) or number (column 618 
percent). cpm=counts per minute. *Cardiovascular Disease is defined a medical history of one 619 
or more of the following: Myocardial Infarction (MI), Heart Valve Disease, Heart Failure, 620 
Atrial Fibrillation, Angina, Stroke, Angioplasty/Coronary Artery Bypass Graft, Leg 621 
Angioplasty/bypass, Peripheral Vascular Disease. 622 
 623 
Variable All 
Participants (N) 509 
Age (years) 64 ± 8 
Female 176 (34.6) 
Current smokers 35 (6.9) 
Glycosylated haemoglobin (HbA1c) (%)  5.9 ± 0.4 
HbA1c (mmol/mol) 41.0 ± 2.0 
Total cholesterol (mmol/L) 5.1 ± 1.0 
LDL (mmol/L) 3.1 ± 0.9 
HDL (mmol/L) 1.4 (0.4) 









Cardiovascular disease* 176 (34.6) 
Accelerometer variables (time in minutes per day) 
Wear-time 853.4 ± 84 
<500cpm 704.3 (127.4) 
500-999cpm 73.3 (40.8) 
1000-1499cpm 29.8 (26.5) 
1500-1999cpm 13.2 (15) 
2000-2499cpm 6.8 (8.66) 
2500-2999cpm 4.0 (5.5) 
3000-3499cpm 2.5 (4.9) 
3500-3999cpm 1.2 (3.8) 
4000-4499cpm 0.3 (2.3) 
>4500cpm 0 (1.5) 





Figure 1a. Forest plot displaying the percentage difference in HDL subclass 626 
concentrations with a 10 minute increase in time spent in bands of 500 counts per minute 627 





Figure 1b. Forest plot displaying the percentage difference in VLDL subclass 631 
concentrations with a 10 minute increase in time spent in bands of 500 counts per minute 632 
of physical activity intensities.  633 
 634 




Figure 1c. Forest plot displaying the percentage difference in VLDL subclass 637 
concentrations with a 10 minute increase in time spent in bands of 500 counts per minute 638 







Figure 1d. Forest plot displaying the percentage difference in IDL and LDL subclass 644 
concentrations with a 10 minute increase in time spent in bands of 500 counts per minute 645 
of physical activity intensities.  646 
  647 
 648 
 649 
  650 
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Figure 2. Forest plot displaying the percentage difference in apolipoproteins with a 10 651 
minute increase in time spent in bands of 500 counts per minute of physical activity 652 
intensities.  653 
 654 
 655 




Figure 3. Forest plot displaying the percentage difference in lipoprotein particle size 658 
with a 10 minute increase in time spent in bands of 500 counts per minute of physical 659 
activity intensities.  660 
 661 
Colours broadly represent commonly used accelerometer cut points for low levels of physical 662 
activity, which includes sedentary behaviour (red) (<500cpm), light (blue) (≥500-<2000cpm) 663 
and MVPA (green) (≥2000 counts per minute). 664 
 665 
